Literature DB >> 17353034

Antiviral activity of human beta-defensin 3 against vaccinia virus.

Michael D Howell, Joanne E Streib, Donald Y M Leung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17353034      PMCID： PMC2668144          DOI： 10.1016/j.jaci.2007.01.044

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

Review 1.  Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report.

Authors:  Cezmi A Akdis; Mübeccel Akdis; Thomas Bieber; Carsten Bindslev-Jensen; Mark Boguniewicz; Philippe Eigenmann; Qutayba Hamid; Alexander Kapp; Donald Y M Leung; Jasna Lipozencic; Thomas A Luger; Antonella Muraro; Natalija Novak; Thomas A E Platts-Mills; Lanny Rosenwasser; Annika Scheynius; F Estelle R Simons; Jonathan Spergel; Kristiina Turjanmaa; Ulrich Wahn; Stefan Weidinger; Thomas Werfel; Torsten Zuberbier
Journal:  J Allergy Clin Immunol       Date:  2006-07       Impact factor: 10.793

Review 2.  Cytokines and chemokines orchestrate atopic skin inflammation.

Authors:  Bernhard Homey; Martin Steinhoff; Thomas Ruzicka; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2006-07       Impact factor: 10.793

Review 3.  Innate immune defects in atopic dermatitis.

Authors:  Laura Y McGirt; Lisa A Beck
Journal:  J Allergy Clin Immunol       Date:  2006-06-06       Impact factor: 10.793

4.  Mechanism of HBD-3 deficiency in atopic dermatitis.

Authors:  Michael D Howell; Mark Boguniewicz; Saveria Pastore; Natalija Novak; Thomas Bieber; Giampiero Girolomoni; Donald Y M Leung
Journal:  Clin Immunol       Date:  2006-10-02       Impact factor: 3.969

5.  Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis.

Authors:  Michael D Howell; Natalija Novak; Thomas Bieber; Saveria Pastore; Giampiero Girolomoni; Mark Boguniewicz; Joanne Streib; Cathy Wong; Richard L Gallo; Donald Y M Leung
Journal:  J Invest Dermatol       Date:  2005-10       Impact factor: 8.551

Review 6.  10. Atopic dermatitis.

Authors:  Mark Boguniewicz; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2006-02       Impact factor: 10.793

7.  Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum.

Authors:  Michael D Howell; James F Jones; Kevin O Kisich; Joanne E Streib; Richard L Gallo; Donald Y M Leung
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

8.  Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus.

Authors:  Michael D Howell; Richard L Gallo; Mark Boguniewicz; James F Jones; Cathy Wong; Joanne E Streib; Donald Y M Leung
Journal:  Immunity       Date:  2006-03       Impact factor: 31.745

9.  Cathelicidin deficiency predisposes to eczema herpeticum.

Authors:  Michael D Howell; Andreas Wollenberg; Richard L Gallo; Michael Flaig; Joanne E Streib; Cathy Wong; Tatjana Pavicic; Mark Boguniewicz; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2006-02-14       Impact factor: 10.793
  9 in total
  21 in total

1.  Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell status.

Authors:  Joanne Domenico; Joseph J Lucas; Mayumi Fujita; Erwin W Gelfand
Journal:  Int Arch Allergy Immunol       Date:  2012-01-26       Impact factor: 2.749

Review 2.  Defensins in viral infections.

Authors:  Jian Ding; Yi-Ying Chou; Theresa L Chang
Journal:  J Innate Immun       Date:  2009-06-24       Impact factor: 7.349

3.  Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells.

Authors:  Aisling S Dugan; Melissa S Maginnis; Joslynn A Jordan; Megan L Gasparovic; Kate Manley; Rebecca Page; Geoffrey Williams; Edith Porter; Bethany A O'Hara; Walter J Atwood
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

4.  Characterization of host responses against a recombinant fowlpox virus-vectored vaccine expressing the hemagglutinin antigen of an avian influenza virus.

Authors:  Hamid R Hghihghi; Leah R Read; Hakimeh Mohammadi; Yanlong Pei; Claudia Ursprung; Eva Nagy; Shahriar Behboudi; S M Mansour Haeryfar; Shayan Sharif
Journal:  Clin Vaccine Immunol       Date:  2010-01-13

5.  Therapeutic and prophylactic drugs to treat orthopoxvirus infections.

Authors:  Scott Parker; Lauren Handley; R Mark Buller
Journal:  Future Virol       Date:  2008-11       Impact factor: 1.831

Review 6.  Recent insights into atopic dermatitis and implications for management of infectious complications.

Authors:  Mark Boguniewicz; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2010-01       Impact factor: 10.793

7.  Upregulation of human β-defensin-3 and cathelicidin LL-37 in Kaposi's sarcoma.

Authors:  Hanan Fathy; Maha M Amin; Abdel-Hady El-Gilany
Journal:  F1000Res       Date:  2012-10-26

Review 8.  Antiviral Activities of Human Host Defense Peptides.

Authors:  David C Brice; Gill Diamond
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

9.  An Immunoinformatics Approach for SARS-CoV-2 in Latam Populations and Multi-Epitope Vaccine Candidate Directed towards the World's Population.

Authors:  Andrés Felipe Cuspoca; Laura Lorena Díaz; Alvaro Fernando Acosta; Marcela Katherine Peñaloza; Yardany Rafael Méndez; Diana Carolina Clavijo; Juvenal Yosa Reyes
Journal:  Vaccines (Basel)       Date:  2021-06-01

10.  Ceragenins: a class of antiviral compounds to treat orthopox infections.

Authors:  Michael D Howell; Joanne E Streib; Byung Eui Kim; Leighann J Lesley; Annegret P Dunlap; Dianliang Geng; Yanshu Feng; Paul B Savage; Donald Y M Leung
Journal:  J Invest Dermatol       Date:  2009-06-11       Impact factor: 8.551
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.